• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PYC 4.00% 9.6¢

PYC THERAPEUTICS LIMITED

PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company... PYC Therapeutics Limited is an Australia-based clinical-stage biotechnology company creating a new generation of ribonucleic acid (RNA) therapies to change the lives of patients with genetic diseases. The Company utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The Company's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PYC 19:49 19 1.9K
19:49 Last post  Counterfiat Comments Created with Sketch.  19  Views Created with Sketch.  1.9K 
PYC 09:24 3 1.0K
09:24 Last post  Malown1 Comments Created with Sketch.  3  Views Created with Sketch.  1.0K 
PYC
PYC Filed Another Patent
08/05/24 19 11K
TRENDING NEWS

What does it take to get a new drug to market in Australia?

NEWS
09 May 2024
08/05/24 Last post  Eaglenebula Comments Created with Sketch.  19  Views Created with Sketch.  11K 
PYC
PYC Chart and Technical Analysis
2 3
07/05/24 126 52K
07/05/24 Last post  travelbug2 Comments Created with Sketch.  126  Views Created with Sketch.  52K 
PYC 06/05/24 9 3.5K
06/05/24 Last post  grimloq Comments Created with Sketch.  9  Views Created with Sketch.  3.5K 
PYC
PYC - General Discussion
3 4 5
03/05/24 266 117K
03/05/24 Last post  drays Comments Created with Sketch.  266  Views Created with Sketch.  117K 
PYC 01/05/24 1 822
01/05/24 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  822 
PYC 01/05/24 14 5.5K
01/05/24 Last post  hottod Comments Created with Sketch.  14  Views Created with Sketch.  5.5K 

See All Discussions arrow Created with Sketch.

Timeline

Q2 2024 Investor Webinar Presentation
09 May 09:31
 
Presentation of RP11 Clinical Trial Data at ARVO Conference
06 May 08:56
 
Ceasing to be a substantial holder
01 May 16:48
 
Q2 Investor Webinar 9 May 2024
01 May 09:47
 
Application for quotation of securities - PYC
30 Apr 09:53
 
RP11 Drug Candidate Progressing to Mid-Stage Human Trials
29 Apr 09:29
 
View More arrow Created with Sketch.
(20min delay)
Last
9.6¢
Change
-0.004(4.00%)
Mkt cap ! $447.9M
Open High Low Value Volume
10.0¢ 10.5¢ 9.5¢ $189.9K 1.928M

Buyers (Bids)

No. Vol. Price($)
1 57296 9.6¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 36762 1
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
9.7¢
  Change
-0.004 ( 3.50 %)
Open High Low Volume
10.0¢ 10.3¢ 9.5¢ 754579
Last updated 15.45pm 09/05/2024 ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.